A Randomized, Open-Label Study Comparing the Combination of YONDELIS® and DOXIL®/CAELYX® With DOXIL®/CAELYX® Monotherapy for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
PhasePhase 3 - a treatment has shown activity against a particular disease, where it is either added to existing treatment or compared to the standard treatment.
Inclusion and Exclusion Criteria
Please contact Anayansi Miloud to learn more about the eligibility criteria for this trial. Please use the contact form on the right side.
Please contact Anayansi Miloud to learn more about where you can participate in this trial. Please use the contact form on the right side.